Margaret Gamalo

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials

Eric L. Simpson, J.‐P. Lacour, Lynda Spelman et al. · British Journal of Dermatology · 2020 · 363 citations

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Emma Guttman‐Yassky, Jonathan I. Silverberg, Osamu Nemoto et al. · Journal of the American Academy of Dermatology · 2018 · 304 citations

Drug Hypersensitivity, Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis +8

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

Kristian Reich, Kenji Kabashima, Ketty Peris et al. · JAMA Dermatology · 2020 · 267 citations · Full text

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Thomas Bieber, Jacob P. Thyssen, Kristian Reich et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 139 citations · Full text

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

Eric L. Simpson, Seth Forman, Jonathan I. Silverberg et al. · Journal of the American Academy of Dermatology · 2021 · 128 citations

Allergy, Atopic Dermatitis, Allergy Medicine +10